100 related articles for article (PubMed ID: 3224637)
1. Antidepressant-like effects of (+)-oxaprotiline on a behavioral screen.
Marek GJ; Li A; Seiden LS
Eur J Pharmacol; 1988 Nov; 157(2-3):183-8. PubMed ID: 3224637
[TBL] [Abstract][Full Text] [Related]
2. Clinical studies of the effect of (+) and (-)-oxaprotiline upon noradrenaline uptake.
Checkley SA; Thompson C; Burton S; Franey C; Arendt J
Psychopharmacology (Berl); 1985; 87(1):116-8. PubMed ID: 3933029
[TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus properties of (+)-oxaprotiline in rats.
Filip M; Chojnacka-Wójcik E; Przegaliński E
Pol J Pharmacol; 1993; 45(2):151-6. PubMed ID: 8401767
[TBL] [Abstract][Full Text] [Related]
4. Oxaprotiline: induction of central noradrenergic subsensitivity of its (+)-enantiomer.
Mishra R; Gillespie DD; Lovell RA; Robson RD; Sulser F
Life Sci; 1982 May; 30(20):1747-55. PubMed ID: 6285106
[TBL] [Abstract][Full Text] [Related]
5. Single treatments with the antidepressant oxaprotiline and its (+) and (-) enantiomers increase behavioural responses to dopaminergic stimulation in the rat.
Delini-Stula A; Mogilnicka E
J Neural Transm; 1988; 71(2):91-8. PubMed ID: 3346651
[TBL] [Abstract][Full Text] [Related]
6. The effects of single and repeated doses of maprotiline, oxaprotiline and its enantiomers on foot-shock induced fighting in rats.
Mogilnicka E; Boissard CG; Waldmeier PC; Delini-Stula A
Pharmacol Biochem Behav; 1983 Oct; 19(4):719-23. PubMed ID: 6139826
[TBL] [Abstract][Full Text] [Related]
7. Stereospecificity of behavioural and biochemical responses to oxaprotiline--a new antidepressant.
Delini-Stula A; Hauser K; Baumann P; Olpe HR; Waldmeier P; Storni A
Adv Biochem Psychopharmacol; 1982; 31():265-75. PubMed ID: 6282056
[No Abstract] [Full Text] [Related]
8. The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens.
Maj J; Wedzony K
Eur J Pharmacol; 1988 Jan; 145(2):97-103. PubMed ID: 3350045
[TBL] [Abstract][Full Text] [Related]
9. (+)-Oxaprotiline but not (-)-oxaprotiline given chronically potentiates the aggressive behaviour induced by clonidine.
Maj J; Rogóz Z; Skuza G
J Pharm Pharmacol; 1983 Mar; 35(3):180-1. PubMed ID: 6132979
[No Abstract] [Full Text] [Related]
10. Characterization of the inhibitory effect of some antidepressant drugs on the outward transport of norepinephrine in the ischemic myocardium.
Carlsson L; Abrahamsson T
J Pharmacol Exp Ther; 1988 Nov; 247(2):715-20. PubMed ID: 3263495
[TBL] [Abstract][Full Text] [Related]
11. Effects of oxaprotiline on the response to peer separation in rhesus monkeys.
McKinney WT; Kraemer GW
Biol Psychiatry; 1989 Mar; 25(6):818-21. PubMed ID: 2923944
[No Abstract] [Full Text] [Related]
12. Pharmacological effects of oxaprotiline enantiomers on the central serotonin system.
Maj J; Dereń A; Moryl E
Pol J Pharmacol Pharm; 1989; 41(4):345-57. PubMed ID: 2534522
[TBL] [Abstract][Full Text] [Related]
13. Increased synaptic availability of norepinephrine following desipramine is not essential for increases in GR mRNA. Short communication.
Eiring A; Sulser F
J Neural Transm (Vienna); 1997; 104(11-12):1255-8. PubMed ID: 9503270
[TBL] [Abstract][Full Text] [Related]
14. Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer.
Waldmeier PC; Baumann PA; Hauser K; Maitre L; Storni A
Biochem Pharmacol; 1982 Jun; 31(12):2169-76. PubMed ID: 7115436
[No Abstract] [Full Text] [Related]
15. Depression and sleep disorders. The optical isomers of oxaprotiline and their effect on sleep parameters in healthy subjects.
Gnirss FA
Psychopathology; 1986; 19 Suppl 2():231-8. PubMed ID: 3575626
[TBL] [Abstract][Full Text] [Related]
16. The effect of (+)- and (-)-oxaprotiline administered repeatedly on the dopamine system.
Maj J; Klimek V; Rogóz Z; Skuza G; Sowińska H
J Neural Transm Gen Sect; 1991; 86(1):11-23. PubMed ID: 1751026
[TBL] [Abstract][Full Text] [Related]
17. Actions of oxaprotiline in the rat hippocampal slice.
Birnstiel S; Haas HL
Prog Neuropsychopharmacol Biol Psychiatry; 1992 Sep; 16(5):717-25. PubMed ID: 1496127
[TBL] [Abstract][Full Text] [Related]
18. The acute and chronic effects of (+) and (-) oxaprotiline upon melatonin secretion in normal subjects.
Palazidou E; Skene D; Arendt J; Everitt B; Checkley SA
Psychol Med; 1992 Feb; 22(1):61-7. PubMed ID: 1315445
[TBL] [Abstract][Full Text] [Related]
19. Oxaprotiline: enantioselective noradrenaline uptake inhibition indicated by intravenous amine pressor tests but not alpha 2-adrenoceptor binding to intact platelets in man.
Reimann IW; Firkusny L; Antonin KH; Bieck PR
Eur J Clin Pharmacol; 1993; 44(1):93-5. PubMed ID: 8382162
[TBL] [Abstract][Full Text] [Related]
20. The metabolic fate of [14C]oxaprotiline.HCl in man. II. Isolation and identification of metabolites.
Dieterle W; Faigle JW; Kriemler HP; Winkler T
Xenobiotica; 1984 Apr; 14(4):311-9. PubMed ID: 6464501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
